Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia

Molecular Psychiatry

Volumn 7, Issue 6, 2002, Pages 571-578

  Vawter, M P ^a   Thatcher, L ^a   Usen, N ^a   Hyde, T M ^a   Kleinman, J E ^a   Freed, W J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Bipolar disorder; Hippocampus; Mood disorder; Schizophrenia; Synapsin; Synaptophysin

Indexed keywords

HALOPERIDOL; LITHIUM; SYNAPSIN; SYNAPSIN 1A; SYNAPSIN 2A; SYNAPSIN 3A; SYNAPSIN I; SYNAPSIN II; SYNAPTOPHYSIN; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SCHIZOPHRENIA; STATISTICAL ANALYSIS; SUICIDE; WESTERN BLOTTING; AUTOPSY; BIPOLAR DISORDER; CAUSE OF DEATH; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE;

AUTOPSY; BIPOLAR DISORDER; CAUSE OF DEATH; COMPARATIVE STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MIDDLE AGE; REFERENCE VALUES; SCHIZOPHRENIA; SUICIDE; SUPPORT, NON-U.S. GOV'T; SYNAPSINS; HUMANS; MIDDLE AGED;

EID: 0036024259     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001158     Document Type: Article

References (42)

1. The neuropathology of schizophrenia
2. A molecular model for bipolar affective disorder
3. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study
4. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities
5. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study
6. Increased dopamine-receptor sensitivity in schizophrenia
7. A two-process theory of schizophrenia: Evidence from studies in post-mortem brain
8. Implications of normal brain development for the pathogenesis of schizophrenia
9. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay
10. Schizophrenia: Genetics and the maternal immune response to viral infection
11. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited
12. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
13. The neuropathology of schizophrenia. A critical review of the data and their interpretation
14. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
15. SNAP-25 deficit and hippocampal connectivity in schizophrenia
16. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
17. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
18. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections
19. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex
20. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia
21. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
22. Synapsins as regulators of neurotransmitter release
23. Synapsins: Mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins
24. 2+
25. A third member of the synapsin gene family
26. A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12
27. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families
28. Neuropathology of suicide. A review and an approach
29. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
30. Abnormal expression of cell recognition molecules in schizophrenia
31. Distinct pools of synaptic vesicles in neuro-transmitter release
32. Regulation of synaptotagmin I phosphorylation by multiple protein kinases
33. A quantitative method for assessing protein abundance using enhanced chemiluminescence
34. Quantification of a neurotrophin receptor from submilligram quantities of brain tissue using western blotting
35. Variation in expression of genes used for normalization of Northern blots after induction of cell proliferation
36. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: Tissue- and treatment-specificity
37. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
38. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique
39. An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults
40. Protein III, a neuron-specific phosphoprotein: Variant forms found in human brain
41. Synapsin Ia, synapsin Ib, protein IIIa, and protein IIIb, four related synaptic vesicle-associated phosphoproteins, share regional and cellular localization in rat brain